SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-21-000535
Filing Date
2021-06-17
Accepted
2021-06-17 09:49:31
Documents
2
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1698
2 EXHIBIT 24 TO FORM 3 FOR PIERRE CALOZ uniqurepoa_060721.htm EX-24 4836
  Complete submission text file 0000904454-21-000535.txt   7913
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 P7 11058BP
Business Address
CALOZ PIERRE (Reporting) CIK: 0001867944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 211023575